CD19+ lineage chimerism, an early biomarker after anti-CD19 CAR-T cell therapy in patients previously receiving a hematopoietic stem cell transplantation.
Martínez-Romera I, Galán-Gómez V, González-Martínez B, Guerra García P, San Román Pacheco S, Corral Sánchez D, Mozo Del Castillo Y, Bueno Sánchez D, Sisinni L, González Guerrero A, Castellano Dámaso S, Sánchez Zapardiel E, Ruz Caracuel B, Balas Pérez A, Pérez-Martínez A.
Martínez-Romera I, et al. Among authors: gonzalez martinez b, gonzalez guerrero a.
Front Immunol. 2022 Aug 8;13:960412. doi: 10.3389/fimmu.2022.960412. eCollection 2022.
Front Immunol. 2022.
PMID: 36003375
Free PMC article.